Works matching IS 00126667 AND DT 2018 AND VI 78 AND IP 17
Results: 10
Correction to: Elagolix: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1855, doi. 10.1007/s40265-018-1014-3
- By:
- Publication type:
- Article
Duvelisib: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1847, doi. 10.1007/s40265-018-1013-4
- By:
- Publication type:
- Article
Cemiplimab: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1841, doi. 10.1007/s40265-018-1012-5
- By:
- Publication type:
- Article
Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1817, doi. 10.1007/s40265-018-1010-7
- By:
- Publication type:
- Article
Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court’s Recent Rulings do not Solve Fundamental Barriers to Competition.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1777, doi. 10.1007/s40265-018-1009-0
- By:
- Publication type:
- Article
Tapentadol Prolonged Release: A Review in Pain Management.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1805, doi. 10.1007/s40265-018-1007-2
- By:
- Publication type:
- Article
Vibegron: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1835, doi. 10.1007/s40265-018-1006-3
- By:
- Publication type:
- Article
Fremanezumab: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1829, doi. 10.1007/s40265-018-1004-5
- By:
- Publication type:
- Article
A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1783, doi. 10.1007/s40265-018-0999-y
- By:
- Publication type:
- Article
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1791, doi. 10.1007/s40265-018-0992-5
- By:
- Publication type:
- Article